Trial intelligence / Profile preview

Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients

NCT01044446Phase 4Completed

Sponsor
The Chinese University of Hong Kong
Start
Jan 2010
Primary completion
Aug 2012
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

Phase 4, randomised trial of icodextrin in peritonitis (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Peritoneal dialysate total white cell count at day 3. Started Jan 2010; status: completed.

02

Drugs

icodextrin
03

Conditions

peritonitis

Beyond the preview

Go deeper on NCT01044446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01044446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call